Clustering of ABCB1 and CYP2C19 Genetic Variants Predicts Risk of Major Bleeding and Thrombotic Events in Elderly Patients with Acute Coronary Syndrome Receiving Dual Antiplatelet Therapy with Aspirin and Clopidogrel

被引:0
|
作者
Roberta Galeazzi
Fabiola Olivieri
Liana Spazzafumo
Giuseppina Rose
Alberto Montesanto
Simona Giovagnetti
Sara Cecchini
Gelsomina Malatesta
Raffaele Di Pillo
Roberto Antonicelli
机构
[1] INRCA National Institute,Clinical Laboratory and Molecular Diagnostics
[2] DISCLIMO,Department of Clinical and Molecular Sciences
[3] Università Politecnica delle Marche,Center of Clinical Pathology and Innovative Therapy
[4] INRCA National Institute,Center of Biostatistics
[5] INRCA National Institute,Department of Biology, Ecology and Earth Sciences
[6] University of Calabria,Unit of Radiology
[7] National Institute of Health and Science on Aging (INRCA),Cardiology Unit
[8] National Institute of Health and Science on Aging (INRCA),undefined
来源
Drugs & Aging | 2018年 / 35卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:649 / 656
页数:7
相关论文
共 50 条
  • [21] ANTIPLATELET THERAPY WITH CLOPIDOGREL TAKING INTO ACCOUNT CYP2C19 GENETIC POLYMORPHISMS IN PATIENTS WITH CORONARY HEART DISEASE AFTER CORONARY ARTERY STENTING
    Uzokov, J.
    Alyavi, B.
    Abdullaev, A.
    Muxitdinova, O.
    Ubaydullaeva, Z.
    ATHEROSCLEROSIS, 2021, 331 : E265 - E265
  • [22] Prasugrel or clopidogrel in non-ST-elevation acute coronary syndrome with CYP2C19 genetic variants undergoing percutaneous coronary intervention
    Kim, S. J.
    Kim, M. H.
    Jin, C. D.
    Shin, E. S.
    Ann, S. H.
    Cho, Y. R.
    Park, J. S.
    Park, T. H.
    EUROPEAN HEART JOURNAL, 2018, 39 : 1213 - 1214
  • [23] A BENEFIT-RISK ASSESSMENT OF USING CYP2C19 GENOTYPE INFORMATION TO GUIDE ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME
    Guzauskas, G. F.
    Veenstra, D.
    Hughes, D.
    VALUE IN HEALTH, 2010, 13 (03) : A152 - A153
  • [24] CYP2C19*2 and Other Allelic Variants Affecting Platelet Response to Clopidogrel Tested by Thrombelastography in Patients with Acute Coronary Syndrome
    Liu, Jian
    Nie, Xiao-Yan
    Zhang, Yong
    Lu, Yun
    Shi, Lu-Wen
    Wang, Wei-Min
    CHINESE MEDICAL JOURNAL, 2015, 128 (16) : 2183 - 2188
  • [25] CYP2C19*2 and Other Allelic Variants Affecting Platelet Response to Clopidogrel Tested by Thrombelastography in Patients with Acute Coronary Syndrome
    Liu Jian
    Nie Xiao-Yan
    Zhang Yong
    Lu Yun
    Shi Lu-Wen
    Wang Wei-Min
    中华医学杂志英文版, 2015, 128 (16) : 2183 - 2188
  • [26] Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis
    Mega, Jessica L.
    Close, Sandra L.
    Wiviott, Stephen D.
    Shen, Lei
    Walker, Joseph R.
    Simon, Tabassome
    Antman, Elliott M.
    Braunwald, Eugene
    Sabatine, Marc S.
    LANCET, 2010, 376 (9749): : 1312 - 1319
  • [27] Clinical Utility of CYP2C19 Genotyping to Guide Antiplatelet Therapy in Patients With an Acute Coronary Syndrome or Undergoing Percutaneous Coronary Intervention
    Klein, Melissa D.
    Williams, Alexis K.
    Lee, Craig R.
    Stouffer, George A.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2019, 39 (04) : 647 - 652
  • [28] Effect of CYP2C19 genetic variants on bleeding and major adverse cardiovascular events in a cohort of Arab patients undergoing percutaneous coronary intervention and stent implantation
    Ali, Zainab Omer
    Bader, Loulia
    Mohammed, Shaaban
    Arafa, Salaheddin
    Arabi, Abdulrahman
    Cavallari, Larisa
    Langaee, Taimour
    Mraiche, Fatima
    Rizk, Nasser
    Awaisu, Ahmed
    Shahin, Mohamed H.
    Elewa, Hazem
    PHARMACOGENETICS AND GENOMICS, 2022, 32 (05): : 183 - 191
  • [29] The Impact of CYP2C19, ABCB1 Genes Polymorphisms and CYP3A4 Isoenzyme Activity on the Incidence of Stent Implantation Complications for Patients With an Acute Coronary Syndrome
    Mirzaev, Karin Badavievich
    Rytkin, Eric
    Grishina, Elena Anatolyevna
    Smirnov, Valery Valeryevich
    Ryzhikova, Kristina Anatolyevna
    Sozaeva, Zhannet Alimovna
    Andreev, Denis Anatolyevich
    Sychev, Dmitrij Alekseevitch
    JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (03) : S6 - S6
  • [30] Cost-effectiveness of CYP2C19 LOF-guided antiplatelet therapy in Chinese patients with acute coronary syndrome
    Fu, Yu
    Zhang, Xin-yi
    Qin, Si-bei
    Nie, Xiao-yan
    Shi, Lu-wen
    Shao, Hong
    Liu, Han
    PHARMACOGENOMICS, 2020, 21 (01) : 33 - 42